Camille Tlemsani

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

International journal of molecular sciences

JCO precision oncology

Cancers

NPJ precision oncology

Hopital Cochin

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hopital Cochin Nov 01 2014

France

MD :: oncology

Publications

Jean-Stéphane Giraud, Anne Jouinot, Eric Pasmant, Camille Tlemsani
NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patients. NPJ precision oncology 8 (1) (2024)
Jean-Stéphane Giraud, Anne Jouinot, Eric Pasmant, Camille Tlemsani
NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patients. NPJ precision oncology 8 (1) (2024)
Michele Bottosso, Benjamin Verret, Olivier Caron, Nadim Hamzaoui, Éric Pasmant, François-Xavier Danlos, Pascaline Boudou-Rouquette, Arunya Srikaran, Hélène Blons, Valentina Guarneri, Sherene Loi, Fabrice Andre, Camille Tlemsani
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO precision oncology 8 (2024)
Nicolas Penel, Sylvie Bonvalot, Marie-Cécile Le Deley, Antoine Italiano, Camille Tlemsani, Diane Pannier, Clémence Leguillette, Jean-Emmanuel Kurtz, Maud Toulmonde, Julien Thery, Daniel Orbach, Pascale Dubray-Longeras, Benjamin Verret, François Bertucci, Cécile Guillemet, Lucie Laroche, Armelle Dufresne, Jean Yves Blay, Axel Le Cesne
Pain in desmoid-type fibromatosis: prevalence, determinants, and prognosis value. International journal of cancer (2023)
Camille Tlemsani, Frédérique Larousserie, Sixtine De Percin, Virginie Audard, Djihad Hadjadj, Jeanne Chen, David Biau, Philippe Anract, Benoit Terris, François Goldwasser, Éric Pasmant, Pascaline Boudou-Rouquette
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options. International journal of molecular sciences 24 (2) (2023)
Camille Tlemsani, Frédérique Larousserie, Sixtine De Percin, Virginie Audard, Djihad Hadjadj, Jeanne Chen, David Biau, Philippe Anract, Benoit Terris, François Goldwasser, Éric Pasmant, Pascaline Boudou-Rouquette
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options. International journal of molecular sciences 24 (2) (2023)
Diaddin Hamdan, Laetitia Marisa, Camille Tlemsani, Eurydice Angeli, Michael Soussan, Nicolas Derive, Pierre Laurent-Puig, Guilhem Bousquet
Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? JCO precision oncology 7 (2023)
Jean-Stéphane Giraud, Ivan Bièche, Éric Pasmant, Camille Tlemsani
NF1 alterations in cancers: therapeutic implications in precision medicine. Expert opinion on investigational drugs (2023)
Diaddin Hamdan, Laetitia Marisa, Camille Tlemsani, Eurydice Angeli, Michael Soussan, Nicolas Derive, Pierre Laurent-Puig, Guilhem Bousquet
Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? JCO precision oncology 7 (2023)
Camille Tlemsani, Frédérique Larousserie, Sixtine De Percin, Virginie Audard, Djihad Hadjadj, Jeanne Chen, David Biau, Philippe Anract, Benoit Terris, François Goldwasser, Éric Pasmant, Pascaline Boudou-Rouquette
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options. International journal of molecular sciences 24 (2) (2023)
Nicolas Penel, Sylvie Bonvalot, Marie-Cécile Le Deley, Antoine Italiano, Camille Tlemsani, Diane Pannier, Clémence Leguillette, Jean-Emmanuel Kurtz, Maud Toulmonde, Julien Thery, Daniel Orbach, Pascale Dubray-Longeras, Benjamin Verret, François Bertucci, Cécile Guillemet, Lucie Laroche, Armelle Dufresne, Jean Yves Blay, Axel Le Cesne
Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value. International journal of cancer (2023)
Camille Tlemsani, Frédérique Larousserie, Sixtine De Percin, Virginie Audard, Djihad Hadjadj, Jeanne Chen, David Biau, Philippe Anract, Benoit Terris, François Goldwasser, Éric Pasmant, Pascaline Boudou-Rouquette
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options. International journal of molecular sciences 24 (2) (2023)
Yohan Fayet, Christine Chevreau, Gauthier Decanter, Cécile Dalban, Pierre Meeus, Sébastien Carrère, Leila Haddag-Miliani, François Le Loarer, Sylvain Causeret, Daniel Orbach, Michelle Kind, Louis-Romée Le Nail, Gwenaël Ferron, Hélène Labrosse, Loïc Chaigneau, François Bertucci, Jean-Christophe Ruzic, Valérie Le Brun Ly, Fadila Farsi, Emmanuelle Bompas, Sabine Noal, Aurore Vozy, Agnes Ducoulombier, Clément Bonnet, Sylvie Chabaud, Francoise Ducimetiere, Camille Tlemsani, Mickaël Ropars, Olivier Collard, Paul Michelin, Justine Gantzer, Pascale Dubray-Longeras, Maria Rios, Pauline Soibinet, Axel Le Cesne, Florence Duffaud, Marie Karanian, François Gouin, Raphaël Tétreau, Charles Honoré, Jean-Michel Coindre, Isabelle L Ray-Coquard, Sylvie Bonvalot, Jean Yves Blay
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome? Cancers 14 (11) (2022)
Marie-Sophie Minot-This, Pascaline Boudou-Rouquette, Anne Jouinot, Sixtine de Percin, David Balakirouchenane, Nihel Khoudour, Camille Tlemsani, Jonathan Chauvin, Audrey Thomas-Schoemann, François Goldwasser, Benoit Blanchet, Jérôme Alexandre
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients. Pharmaceutics 14 (6) (2022)
Camille Tlemsani, Nobuyuki Takahashi, Lorinc Sandor Pongor, Vinodh N Rajapakse, Manoj Tyagi, Xinyu Wen, Grace-Ann Fasaye, Keith T Schmidt, Parth Desai, Chul Kim, Arun Rajan, Shannon Swift, Linda Sciuto, Rasa Vilimas, Santhana Webb, Samantha Nichols, William Douglas Figg, Yves Pommier, Kathleen Calzone, Seth M Steinberg, Jun S Wei, Udayan Guha, Clesson E Turner, Javed Khan, Anish Thomas
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies. Science translational medicine 13 (578) (2021)
Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, Elizabeth Fabre, Marie Wislez, Marco Alifano, Karen Leroy, Pascaline Boudou-Rouquette, Camille Tlemsani, Nihel Khoudour, Jennifer Arrondeau, Audrey Thomas-Schoemann, Hélène Blons, Audrey Mansuet-Lupo, Diane Damotte, Michel Vidal, François Goldwasser, Jérôme Alexandre, Benoit Blanchet
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study. Cancers 12 (2) (2020)
Laurence Pacot, Cyril Burin des Roziers, Ingrid Laurendeau, Audrey Briand-Suleau, Audrey Coustier, Théodora Mayard, Camille Tlemsani, Laurence Faivre, Quentin Thomas, Diana Rodriguez, Sophie Blesson, Hélène Dollfus, Yvon-Gauthier Muller, Béatrice Parfait, Michel Vidaud, Brigitte Gilbert-Dussardier, Catherine Yardin, Benjamin Dauriat, Christian Derancourt, Dominique Vidaud, Éric Pasmant
One NF1 Mutation may Conceal Another. Genes 10 (9) (2019)
Camille Tlemsani, Nicolas Pécuchet, Aurelia Gruber, Ingrid Laurendeau, Claire Danel, Marc Riquet, Françoise Le Pimpec-Barthes, Elizabeth Fabre, Audrey Mansuet-Lupo, Diane Damotte, Marco Alifano, Armelle Luscan, Benoit Rousseau, Dominique Vidaud, Jennifer Varin, Beatrice Parfait, Ivan Bieche, Karen Leroy, Pierre Laurent-Puig, Benoit Terris, Helene Blons, Michel Vidaud, Eric Pasmant
NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas. Cancer medicine 8 (9) (2019)

Camille Tlemsani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Camille Tlemsani